Literature DB >> 25410736

Direct In Vivo Human Intestinal Permeability (Peff ) Determined with Different Clinical Perfusion and Intubation Methods.

David Dahlgren1, Carl Roos1, Erik Sjögren1, Hans Lennernäs1.   

Abstract

Regional in vivo human intestinal effective permeability (Peff ) is calculated by measuring the disappearance rate of substances during intestinal perfusion. Peff is the most relevant parameter in the prediction of rate and extent of drug absorption from all parts of the intestine. Today, human intestinal perfusions are not performed on a routine basis in drug development. Therefore, it would be beneficial to increase the accuracy of the in vitro and in silico tools used to evaluate the intestinal Peff of novel drugs. This review compiles historical Peff data from 273 individual measurements of 80 substances from 61 studies performed in all parts of the human intestinal tract. These substances include: drugs, monosaccharaides, amino acids, dipeptides, vitamins, steroids, bile acids, ions, fatty acids, and water. The review also discusses the determination and prediction of Peff using in vitro and in silico methods such as quantitative structure-activity relationship, Caco-2, Ussing chamber, animal intestinal perfusion, and physiologically based pharmacokinetic (PBPK) modeling. Finally, we briefly outline how to acquire accurate human intestinal Peff data by deconvolution of plasma concentration-time profiles following regional intestinal bolus dosing.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  absorption; bioavailability; biopharmaceutics classification system; human intestinal permeability; intestinal perfusion; intestinal transporters; oral drug delivery; pharmacokinetics; physiologically based pharmacokinetic modeling

Mesh:

Year:  2014        PMID: 25410736     DOI: 10.1002/jps.24258

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  11 in total

1.  "Development of Fixed Dose Combination Products" Workshop Report: Considerations of Gastrointestinal Physiology and Overall Development Strategy.

Authors:  Bart Hens; Maura Corsetti; Marival Bermejo; Raimar Löbenberg; Pablo M González; Amitava Mitra; Divyakant Desai; Dakshina Murthy Chilukuri; Alexis Aceituno
Journal:  AAPS J       Date:  2019-06-06       Impact factor: 4.009

2.  In Vitro Evaluation of Absorption Characteristics of Peramivir for Oral Delivery.

Authors:  Ying Li; Zhiyuan Wang; Xin Li; Wei Gong; Xiangyang Xie; Yang Yang; Wu Zhong; Aiping Zheng
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-10       Impact factor: 2.441

Review 3.  Application of In Vivo Imaging Techniques and Diagnostic Tools in Oral Drug Delivery Research.

Authors:  Stefan Senekowitsch; Philipp Schick; Bertil Abrahamsson; Patrick Augustijns; Thomas Gießmann; Hans Lennernäs; Christophe Matthys; Luca Marciani; Xavier Pepin; Alan Perkins; Maximilian Feldmüller; Sarah Sulaiman; Werner Weitschies; Clive G Wilson; Maura Corsetti; Mirko Koziolek
Journal:  Pharmaceutics       Date:  2022-04-06       Impact factor: 6.525

4.  Translating Human Effective Jejunal Intestinal Permeability to Surface-Dependent Intrinsic Permeability: a Pragmatic Method for a More Mechanistic Prediction of Regional Oral Drug Absorption.

Authors:  Andrés Olivares-Morales; Hans Lennernäs; Leon Aarons; Amin Rostami-Hodjegan
Journal:  AAPS J       Date:  2015-05-19       Impact factor: 4.009

5.  A quantitative model for metabolic intervention using gut microbes.

Authors:  Zachary J S Mays; Nikhil U Nair
Journal:  Biotechnol Prog       Date:  2021-01-16

Review 6.  Intestinal absorption of BCS class II drugs administered as nanoparticles: A review based on in vivo data from intestinal perfusion models.

Authors:  David Dahlgren; Erik Sjögren; Hans Lennernäs
Journal:  ADMET DMPK       Date:  2020-09-17

7.  The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities.

Authors:  Steve O'Hagan; Douglas B Kell
Journal:  PeerJ       Date:  2015-11-17       Impact factor: 2.984

8.  An in vitro toolbox to accelerate anti-malarial drug discovery and development.

Authors:  Susan A Charman; Alice Andreu; Helena Barker; Scott Blundell; Anna Campbell; Michael Campbell; Gong Chen; Francis C K Chiu; Elly Crighton; Kasiram Katneni; Julia Morizzi; Rahul Patil; Thao Pham; Eileen Ryan; Jessica Saunders; David M Shackleford; Karen L White; Lisa Almond; Maurice Dickins; Dennis A Smith; Joerg J Moehrle; Jeremy N Burrows; Nada Abla
Journal:  Malar J       Date:  2020-01-02       Impact factor: 2.979

9.  Synthesis and Evaluation of PEG-PR for Water Flux Correction in an In Situ Rat Perfusion Model.

Authors:  Guo Chen; Xingqi Min; Qunqun Zhang; Zhiqiang Zhang; Meiqiang Wen; Jun Yang; Meijuan Zou; Wei Sun; Gang Cheng
Journal:  Molecules       Date:  2020-11-04       Impact factor: 4.411

10.  Using Ex Vivo Porcine Jejunum to Identify Membrane Transporter Substrates: A Screening Tool for Early-Stage Drug Development.

Authors:  Yvonne E Arnold; Yogeshvar N Kalia
Journal:  Biomedicines       Date:  2020-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.